Summary
- In a study of patients with systemic sclerosis, orofacial features were found to be a major concern.
- Hyaluronidase injections have been shown to improve orofacial changes in patients with scleroderma.
- Research has shown that multiple treatments may be needed for optimal results.
- Nerve blocks are recommended for injecting HA filler or hyaluronidase to minimize pain.
- The treatment has been found to be effective and can be performed in a general dermatologist’s office.
A new treatment has been found to help patients with scleroderma improve the appearance of their lips and mouth. Researchers have discovered that hyaluronidase injections can help patients with scleroderma-induced microstomia, a condition that causes the mouth to become smaller.
In a recent study, a woman with scleroderma received hyaluronidase injections over several months and reported an improved ability to eat, undergo dental treatment, and close her mouth more easily. The treatment involves injecting hyaluronidase into the affected areas, and patients may need multiple treatments to see the full effects.
Another study involving four women with autoimmune sclerosing conditions also showed improvement in mouth opening capacity and overall satisfaction with the treatment. The researchers found that patients continued to respond well to the treatment even after multiple injections.
Overall, the treatment involves using hyaluronic acid filler to increase the size of the mouth opening. Researchers have found that patients typically need three to four treatments to reach the desired effect, and the results can last over time. This new treatment option offers hope for patients with scleroderma who are struggling with changes in their facial features.
Source link
Dermatology,Rheumatology,Dentistry and Oral Health